<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03297372</url>
  </required_header>
  <id_info>
    <org_study_id>PHY1604</org_study_id>
    <nct_id>NCT03297372</nct_id>
  </id_info>
  <brief_title>Visual Performance Intraocular Lens (IOL) MicroPure 1.2.3.</brief_title>
  <official_title>Clinical Study to Investigate Visual Performance of Hydrophobic Monofocal IOL: MicroPure 1.2.3.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Physiol</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Physiol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The clinical investigation is a post-market clinical follow up study whereby patients
      undergoing routine cataract surgery will have monolateral implantation of a commercially
      available, CE approved monofocal intraocular lens MicroPure 1.2.3. (PhysIOL, Liège, Belgium).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The examinations consist of visual acuity data, contrast sensitivity exams, slitlamp
      examinations and posterior capsule opacification (PCO) grading.

      Follow up will be up to 24 months postoperative.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>monocular Corrected Distance Visual Acuity (CDVA) under photopic conditions</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>The primary study end point is to show statistically equal visual acuity outcomes on monocular Corrected Distance Visual Acuity (CDVA) under photopic conditions compared to literature data on a monofocal hydrophobic IOL (Alcon - Acrysof SN60AT).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Posterior capsule opacification (PCO) grading</measure>
    <time_frame>2 years postoperative</time_frame>
    <description>grade of the PCO determined by slitlamp</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected Distance Visual acuity (UDVA)</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Monocular Uncorrected Distance Visual acuity (UDVA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Contrast Sensitivity under photopic and mesopic light conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glistening assessment</measure>
    <time_frame>2 years postoperative</time_frame>
    <description>Assessment of glistenings by slitlamp determination</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cataract</condition>
  <condition>Lens Opacities</condition>
  <arm_group>
    <arm_group_label>IOL Implantation experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of Micropure 1.2.3. in one of the eyes of the study subject</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOL implantation</intervention_name>
    <description>Implantation of monofocal IOL Micropure 1.2.3</description>
    <arm_group_label>IOL Implantation experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataractous eyes with no comorbidity

          -  Availability, willingness and sufficient cognitive awareness to comply with
             examination procedures

          -  Signed informed consent

        Exclusion Criteria:

          -  Irregular astigmatism

          -  Age of patient &lt; 45 years

          -  Regular corneal astigmatism &gt; 0.75 D on study eye as measured by an automatic
             keratometer (regularity determined by the topography of the keratometry)

          -  Difficulty for cooperation (distance from their home, general health condition)

          -  Acute or chronic disease or illness that would increase risk or confound study results
             (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)

          -  Any ocular comorbidity

          -  History of ocular trauma or prior ocular surgery including refractive procedures

          -  Capsule or zonular abnormalities that may affect postoperative centration or tilt of
             the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)

          -  Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils
             that do not dilate under mesopic/scotopic conditions)

          -  Complicated surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Domenico Schiano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione GB Bietti - IRCCS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jochen Kandulla, PhD</last_name>
    <phone>+49 157 862 75 281</phone>
    <email>j.kandulla@physiol.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sally Lamborelle</last_name>
    <phone>+32 4 361 45 49</phone>
    <email>s.lamborelle@physiol.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Giovanni Addolorata - presidio Britannico</name>
      <address>
        <city>Rome</city>
        <zip>00184</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Augusto Pocobelli, MD</last_name>
      <phone>+39 6 77052950</phone>
      <email>apocobelli@hsangiovanni.roma.it</email>
    </contact>
    <investigator>
      <last_name>Augusto Pocobelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione GB Bietti - IRCCS</name>
      <address>
        <city>Rome</city>
        <zip>00198</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenico Schiano, MD</last_name>
      <phone>+39 6 85356727</phone>
      <email>do.schiano@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Domenico Schiano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2017</study_first_submitted>
  <study_first_submitted_qc>September 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2017</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intraocular lens</keyword>
  <keyword>monofocal</keyword>
  <keyword>cataract</keyword>
  <keyword>PhysIOL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

